Drug Research
U.S. FDA approves rivaroxaban to help prevent blood clots...
Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. FDA has approved rivaroxaban (Xarelto) for the prevention of venous...
Drug Research
Arctoris Ltd Secures Seed Funding of £3.2 Million to...
Arctoris Ltd, a fully automated drug discovery platform for virtual and traditional biotechnology companies, pharmaceutical corporations and academia, announced that it has successfully closed a...
Drug Research
Novel silica delivery system Nuvec (R) enters final pre-clinical...
N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, has announced results fromthe company’s latest research study into its novel silica nanoparticle for cancer treatments...
Drug Research
Sygnature Discovery moves US base to Kendall Square
Sygnature Discovery, the leading independent drug discovery and pre-clinical services company, has announced its US office has moved. The new office, at 245 First Street...
Drug Research
The rise and rise of Global Pharma Excipients Market
With the rise in the Global Pharma Industry, excipients too are bound to have their share of light. Of late, there has been an increasing...
Drug Research
Sygnature Discovery develops AR molecular visualisation prototype
The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important consideration when designing a new...
Drug Research
Signant Health Brings Its eConsent Solution to China for...
Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.